Enlightening the promising role of nanoparticle-based treatments against Naegleria fowleri-induced primary amoebic meningoencephalitis: A brain-eating disease

Naegleria fowleri, is the causative agent of Primary Amoebic Meningoencephalitis (PAM), a lethal acute brain inflammation with high mortality. The virulent and reproductively active trophozoite stage of N. fowleri migrates to central nervous system (CNS) by entering through nasal passage and causes severe neural infection, brain disease and inflammation with high mortality. In this review we present the current available information about N. fowleri, including its case reports, pathogenesis and the mechanism of host neuroinflammation associated with PAM. Various case reports reveal that the survival rate of patients with PAM is very low. Several anti-microbial, anti-parasitic and anti-inflammatory compounds such as doxycycline, amphotericin, acyclovir, miltefosine, ampicillin, ceftriaxone, azithromycin are widely used to treat PAM. Nanoparticles conjugated drug has now attracted better attention in dealing with free-living amoeba community. Conventional drugs are being conjugated with nanomaterials like gold (Au), sliver (Ag) etc. which have elicited better amoebicidal effect against N. fowleri than unconjugated drugs. This targeted strategy may prove helpful and possibly may reduce neural damage.